首页> 外文期刊>Indian Journal of Medical Microbiology >Severe unresolving Plasmodium falciparum malaria following artemisinin combination therapy: Emergence of drug resistance in Saudi Arabia
【24h】

Severe unresolving Plasmodium falciparum malaria following artemisinin combination therapy: Emergence of drug resistance in Saudi Arabia

机译:青蒿素联合治疗后严重的恶性疟原虫疟疾:沙特阿拉伯出现耐药性

获取原文
           

摘要

A 5-year-old female child presented with fever of 1-week duration after visiting a malaria endemic zone without antimalarial prophylaxis. The patient presented with respiratory distress, decreased level of consciousness and high-grade fever. An elevated parasitaemia reaching 800,000/μl was observed. Antimalarial therapy was initiated with artesunate being administered intravenous (IV) along with IV clindamycin. Contrary to the expectations, there was no resolution of fever. Following a week of unresolved fever, the drug therapy was revised and altered to IV quinine dihydrochloride and IV clindamycin. Emergence of non-responsiveness to artesunate in Saudi Arabia is an alarming sign and requires revision of management protocols.
机译:一名5岁女童在没有疟疾预防措施的疟疾流行区访问后出现1周发烧。患者出现呼吸窘迫,意识下降和高烧。观察到寄生虫血症升高,达到800,000 /μl。抗疟疾治疗始于将青蒿琥酯与克林霉素同时静脉注射(IV)。与期望相反,没有发烧的迹象。一周未解决的发烧后,对药物疗法进行了修改,并更改为静脉注射奎宁二盐酸盐和静脉注射克林霉素。沙特阿拉伯对青蒿琥酯无反应的出现是一个令人震惊的信号,需要修订管理协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号